Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,212,819 papers from all fields of science
Search
Sign In
Create Free Account
Fibrates, lipid modifying drugs, plain
Known as:
Fibrates
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Fibrates
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Integrated approach in the treatment of metabolic syndrome
V. Uchamprina
,
T. Romantsova
,
M. Kalashnikova
2014
Corpus ID: 70431874
The Goal of this study was to investigate the efficacy of the integrated approach for the treatment of metabolic syndrome (MS…
Expand
2014
2014
Комплексный подход в лечении метаболического синдрома
В. А. Учамприна
,
Татьяна Ивановна Романцова
,
М. Ф. Калашникова
2014
Corpus ID: 74938648
The Goal of this study was to investigate the efficacy of the integrated approach for the treatment of metabolic syndrome (MS…
Expand
2010
2010
The role of nonstatin therapy in managing hyperlipidemia.
J. Murrow
American Family Physician
2010
Corpus ID: 26344095
When treating hyperlipidemia, physicians often face the question of the clinical value of nonstatin drugs, including bile acid…
Expand
2008
2008
PPAR{alpha} agonist fenofibrate inhibits IGF-I - mediated growth and DNA repair responses and sensitizes human glioblastoma cells to cisplatin
K. Reiss
,
K. Urbańska
,
L. Delvalle
,
P. Mencel
2008
Corpus ID: 74490829
13020 Background: Recent studies suggest a potential role of lipid lowering drugs, fibrates and statins, in anticancer treatments…
Expand
2005
2005
Antiatherogenic properties of fibrates.
P. Barter
Arteriosclerosis, Thrombosis and Vascular Biology
2005
Corpus ID: 42189186
In an era dominated by the use of statins as agents to reduce cardiovascular risk, fibrates have been largely forgotten. This is…
Expand
2004
2004
Editorial: Novel Factors in the Regulation of β-Cell Function
C. Boitard
,
E. Cerasi
,
S. Efendić
,
J. Henquin
,
D. Steiner
,
E. Ferrannini
2004
Corpus ID: 14514399
Insulin secretion and β-cell biology are the focus of the Servier-IGIS Symposia that have been held yearly since 2000 in St. Jean…
Expand
2004
2004
[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].
Dobordzhginidze Lm
,
Gratsianskiĭ Na
2004
Corpus ID: 77367590
2003
2003
Fibrates and renal function.
M. Gajdoš
,
R. Dzúrik
Clinical Nephrology
2003
Corpus ID: 43558572
Review
2001
Review
2001
The use of fibrates and of statins in preventing atherosclerosis in diabetes
G. Steiner
Current Opinion in Lipidology
2001
Corpus ID: 46408827
Atherosclerotic cardiovascular disease is the most common complication of diabetes. Recent guidelines in the USA have underlined…
Expand
1995
1995
Modulation of cardiac intermediate filament proteins in the chick heart by fibric acid derivatives.
A. Aránega
,
M. C. Velez
,
F. J. Gonzalez
,
C. Melguizo
,
J. Prados
,
A. Aránega
European Journal of Morphology
1995
Corpus ID: 36001103
The effects of different fibrates (bezafibrate, fenofibrate and gemfibrozil) on intermediate filaments were studied in cultured…
Expand